Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study Evaluating the Possible Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease

NCT07001150 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07001150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07001150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study Evaluating the Possible Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
Lead sponsor
Tanta University
Phase
Phase 2
Overall status
Recruiting
Start date
May 10, 2025
Completion date
May 30, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease